Clinical Trials Browser

Phase 4 × Not yet recruiting × Breast × Clear all

NCT07599137 2026-05-20

ADES

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07600164 2026-05-20

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07583134 2026-05-15

B-BIT

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07589699 2026-05-15

Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07490509 2026-04-01

DOSABEMA

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Phase 4 Not yet recruiting

Breast Neoplasms, Obesity

NCT07436663 2026-02-27

SGLT2i/DPPi

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07344974 2026-01-20

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07254221 2025-12-10

ROSUBREAST

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Phase 4 Not yet recruiting

Breast Cancer Patients Treated With T-DXd

NCT07162259 2025-09-09

Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT05871437 2025-09-08

Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT06868017 2025-03-10

Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

Phase 4 Not yet recruiting

HER2 Positive Breast Cancer

NCT06777537 2025-01-16

Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT06613373 2024-09-25

An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT06578299 2024-08-29

Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT06245824 2024-02-07

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Phase 4 Not yet recruiting

Breast Neoplasms

NCT05860907 2023-09-26

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

Phase 4 Not yet recruiting

Breast Neoplasms

NCT05843292 2023-06-06

NeoSTEP

Phase 4 Not yet recruiting

Triple Negative Breast Neoplasms

NCT05841849 2023-05-03

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms, Vomiting

NCT04929548 2022-01-05

Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP

Phase 4 Not yet recruiting

Breast Neoplasms

NCT04137640 2021-07-20

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Phase 4 Not yet recruiting

Breast Neoplasms